TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.
Xu Q, Xu Y, Pan B, Wu L, Ren X, Zhou Y, Mao F, Lin Y, Guan J, Shen S, Zhang X, Wang C, Zhong Y, Zhou L, Liang Z, Zhao H, Sun Q.
Xu Q, et al. Among authors: zhou y, zhou l.
Oncotarget. 2016 Dec 6;7(49):81815-81829. doi: 10.18632/oncotarget.13245.
Oncotarget. 2016.
PMID: 27833085
Free PMC article.